Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) The confirmed patient (or legal guardian) agrees to participate in the study and signs the informed consent form; 2) aged 18 to 65 years; 3) The time interval between the onset of symptoms and random enrollment is within 8 days (the onset of symptoms is mainly based on the occurrence of fever); 4) Real-time fluorescent RT-PCR of respiratory specimens or blood specimens to detect patients with 2019-nCoV nucleic acid positive; 5) Patients were diagnosed as type 3 patients with mild, common and severe cases according to the "Diagnosis and Treatment Scheme for 2019-nCoV (Trial Version 6)".
Exclusion criteria
Exclusion criteria: 1) Any situation where the solution cannot be carried out safely; 2) Allergic constitution, allergic to one or more foods or drugs; 3) Severe basic diseases affecting survival, including uncontrolled clinically significant heart, lung, kidney, digestive, hematological, neuropsychiatric diseases, immune diseases, metabolic diseases or malignant tumors, severe malnutrition; 4) pregnant or lactating women; 5) The patient may be transferred to a non-participating hospital within 72 hours; 6) Those who have continued to use immunosuppressive agents or organ transplants in the past 6 months; 7) Within 15 days before enrollment, during the hospitalization period, any patient who is being treated with antiviral drugs other than this program during treatment; 8) People who cannot cooperate with mental state, suffer from mental illness, have no self-control, and cannot express clearly; 9) History of HBV, HCV, TPPA, HIV, and pancreatitis before infection; 10) Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Routine physical examination;Vital signs: breathing, body temperature (armpit temperature);Blood routine;C-reactive protein;Liver and kidney function test;Myocardial enzyme content;ESR;T cell subsets;Cytokine;Liver, gallbladder, thyroid, and lymph node imaging;Chest CT;Infectious disease test; | — |
Countries
China
Contacts
Public ContactShao Yi
The First Affiliated Hospital of Nanchang University
Outcome results
None listed